dantrolene has been researched along with Cardiovascular Stroke in 8 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dantrolene was reported to suppress ventricular fibrillation (VF) in failing hearts with acute myocardial infarction, but its antiarrhythmic efficacy in regional ischemia-reperfusion (IR) hearts remains debatable." | 7.81 | Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure. ( Chang, PC; Chou, CC; Lee, HL; Wen, MS; Wo, HT; Yeh, SJ, 2015) |
| "Dantrolene prevents arrhythmogenic Ca(2+) release during heart failure (HF)." | 7.80 | Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model. ( Chang, PC; Chou, CC; Lee, HL; Wen, MS; Wo, HT; Wu, D; Yeh, SJ, 2014) |
| "Dantrolene was reported to suppress ventricular fibrillation (VF) in failing hearts with acute myocardial infarction, but its antiarrhythmic efficacy in regional ischemia-reperfusion (IR) hearts remains debatable." | 3.81 | Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure. ( Chang, PC; Chou, CC; Lee, HL; Wen, MS; Wo, HT; Yeh, SJ, 2015) |
| "Dantrolene prevents arrhythmogenic Ca(2+) release during heart failure (HF)." | 3.80 | Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model. ( Chang, PC; Chou, CC; Lee, HL; Wen, MS; Wo, HT; Wu, D; Yeh, SJ, 2014) |
| "Dantrolene-treated rats with myocardial infarction were placed into two different dosage groups." | 1.32 | Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium. ( Feng, X; Malek, S; Meissner, A; Min, JY; Morgan, JP; Simon, R; Wang, J; Wang, JF, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, S | 1 |
| Kobayashi, S | 1 |
| Chang, Y | 1 |
| Nawata, J | 1 |
| Yoshitomi, R | 1 |
| Tanaka, S | 1 |
| Kohno, M | 1 |
| Nakamura, Y | 1 |
| Ishiguchi, H | 1 |
| Suetomi, T | 1 |
| Uchinoumi, H | 1 |
| Oda, T | 1 |
| Okuda, S | 1 |
| Okamura, T | 1 |
| Yamamoto, T | 1 |
| Yano, M | 1 |
| Chou, CC | 2 |
| Wen, MS | 2 |
| Lee, HL | 2 |
| Chang, PC | 2 |
| Wo, HT | 2 |
| Yeh, SJ | 2 |
| Wu, D | 1 |
| Min, JY | 1 |
| Meissner, A | 1 |
| Feng, X | 1 |
| Wang, J | 1 |
| Malek, S | 1 |
| Wang, JF | 1 |
| Simon, R | 1 |
| Morgan, JP | 1 |
| Acikel, M | 1 |
| Buyukokuroglu, ME | 1 |
| Erdogan, F | 1 |
| Aksoy, H | 1 |
| Bozkurt, E | 1 |
| Senocak, H | 1 |
| Parr, MJ | 1 |
| Craft, TM | 1 |
| Adnet, P | 1 |
| Krivosic-Horber, R | 1 |
| Sahn, SA | 1 |
2 reviews available for dantrolene and Cardiovascular Stroke
| Article | Year |
|---|---|
[Calcium inhibitors and anesthesia].
Topics: Analgesics; Anesthesia, General; Anesthetics; Arrhythmias, Cardiac; Brain Ischemia; Calcium Channel | 1988 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Gran | 1985 |
6 other studies available for dantrolene and Cardiovascular Stroke
| Article | Year |
|---|---|
RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Topics: Animals; Arrhythmias, Cardiac; Calmodulin; Dantrolene; Heart Failure; Mice; Myocardial Infarction; M | 2023 |
Dantrolene suppresses ventricular ectopy and arrhythmogenicity with acute myocardial infarction in a langendorff-perfused pacing-induced heart failure rabbit model.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Coronary | 2014 |
Effects of dantrolene on arrhythmogenicity in isolated regional ischemia-reperfusion rabbit hearts with or without pacing-induced heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Dantrolene; Heart; Heart Failure; Heart Ventricles; Myocardial Infa | 2015 |
Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium.
Topics: Animals; Blotting, Western; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Cycloph | 2003 |
Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings.
Topics: Adrenergic beta-Agonists; Animals; Dantrolene; Disease Models, Animal; Heart; Isoproterenol; Male; M | 2005 |
The management of acute poisoning.
Topics: Dantrolene; Fever; Humans; Myocardial Infarction; Poisoning; Unconsciousness | 1993 |